Company Hologic, Inc.

Equities

HOLX

US4364401012

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
77.35 USD +1.55% Intraday chart for Hologic, Inc. +3.08% +8.26%

Business Summary

Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows:

- molecular diagnostics (62.1%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;

- breast health (25.3%): digital mammography and breast biopsy solutions and systems;

- gynecological surgery (10.8%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;

- bone health (1.97%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.

Net sales break down by source of revenue between sales of products (86.2%) and services (13.8%).

Net sales are distributed geographically as follows: the United States (71.3%), Europe (18.3%), Asia/Pacific (7.4%) and other (3%).

Number of employees: 6,990

Sales per Business

USD in Million2022Weight2023Weight Delta
Diagnostics
46.6 %
3,019 62.1 % 1,880 46.6 % -37.71%
Breast Health
35.5 %
1,228 25.2 % 1,433 35.5 % +16.69%
GYN Surgical
15.0 %
523 10.8 % 604 15.0 % +15.55%
Skeletal Health
2.8 %
94 1.9 % 113 2.8 % +21.15%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
75.9 %
3,468 71.3 % 3,058 75.9 % -11.82%
Europe
12.9 %
889 18.3 % 520 12.9 % -41.44%
Asia-Pacific
6.3 %
360 7.4 % 256 6.3 % -28.91%
Rest of the World
4.9 %
147 3.0 % 196 4.9 % +33.88%

Managers

Managers TitleAgeSince
Chief Executive Officer 60 13-12-06
Director of Finance/CFO 54 05-12-31
Chief Operating Officer 44 17-08-31
Chief Tech/Sci/R&D Officer - 21-06-30
Public Communications Contact - 21-05-31
Investor Relations Contact - -
Public Communications Contact - 14-07-31
Comptroller/Controller/Auditor - 18-08-02
Corporate Officer/Principal - -
Corporate Officer/Principal - 23-09-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 60 13-12-06
Director/Board Member 69 17-05-14
Director/Board Member 63 16-11-30
Director/Board Member 53 11-10-31
Director/Board Member 70 07-10-21
Director/Board Member 73 13-05-05
Director/Board Member 60 23-01-01
Director/Board Member 61 18-11-20
Director/Board Member 46 23-09-19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 300,683,521 232,974,156 ( 77.48 %) 65,952,000 ( 21.93 %) 77.48 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.79 %
27,679,701 11.79 % 2 043 M $
T. Rowe Price Investment Management, Inc.
9.403 %
22,071,713 9.403 % 1 629 M $
BlackRock Advisors LLC
7.480 %
17,557,233 7.480 % 1 296 M $
11,104,181 4.731 % 819 M $
BlackRock Life Ltd.
2.681 %
6,292,398 2.681 % 464 M $
Geode Capital Management LLC
2.378 %
5,581,010 2.378 % 412 M $
Victory Capital Management, Inc. (Investment Management)
2.154 %
5,055,048 2.154 % 373 M $
Macquarie Investment Management Business Trust
1.805 %
4,236,966 1.805 % 313 M $
Renaissance Technologies LLC
1.711 %
4,015,902 1.711 % 296 M $
T. Rowe Price International Ltd.
1.510 %
3,544,181 1.510 % 262 M $

Company contact information

Hologic, Inc.

250 Campus Drive

01752, Marlborough

+508 263 2900

http://www.hologic.com
address Hologic, Inc.(HOLX)

Group companies

NameCategory and Sector
Medical Specialties
Medical Distributors